# OnCo record lume-lung-1 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/lume-lung-1/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "lume-lung-1", "NCT00805194" ;
  schema:name "LUME-Lung 1"@en ;
  schema:description "An oral drug against three angiogenic receptors added to second-line chemotherapy; it worked, but only in adenocarcinoma, which is how it is licensed."@en ;
  schema:url <https://onco.cc/trials/lume-lung-1/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT00805194>, <https://doi.org/10.1016/S1470-2045(13)70586-2>, <https://www.nice.org.uk/guidance/ta347> ;
  onco:status "mixed" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/lung-adenocarcinoma/>, <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/technologies/antiangiogenic/>, <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:targets <https://onco.cc/targets/vegf/> ;
  onco:drugs <https://onco.cc/drugs/nintedanib/>, <https://onco.cc/drugs/docetaxel/> ;
  onco:companies <https://onco.cc/companies/boehringer-ingelheim/> ;
  onco:trials <https://onco.cc/trials/revel/> .